Aarti Pharmalabs Ltd (NSE:AARTIPHARM)

Q3 2026 Aarti Pharmalabs Ltd Earnings Call Transcript

Feb 10, 2026 / 10:30 AM GMT

Release Date Price: ₹764.4 (-3.82%)

Transcript

Key Points

Positve

Aarti Pharmalabs Ltd (BOM:543748) reported a significant increase in revenue for Q3 FY26, reaching INR5,425 crores compared to INR471 crores a year ago.
The company declared an interim dividend of INR1.5 per share, indicating a commitment to returning value to shareholders.
The xanthine derivatives segment contributed to 49% of the turnover, with a strong export sales component of 51%.
The CDMO CMO segment is working with 21 customers and has 159 active projects, showing a robust pipeline.
The company is confident in meeting its CDMO revenue guidance for FY26, despite some project delivery delays.

Negative

EBITDA for Q3 FY26 decreased to INR103 crores from INR115 crores in the previous year, indicating margin pressure.
Profit after tax fell to INR44 crores from INR74 crores a year ago, reflecting challenges in profitability.
The API and intermediate business is experiencing margin pressure, with only early signs of recovery.
Expansion projects faced initial hiccups, impacting production plans and causing delays in project deliveries.
The company revised its full-year EBITA growth expectations to be largely in line with last year, citing delays in plant stabilization and softness in the API and intermediate business.

Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

AARP.NS - Aarti Pharmalabs Ltd
Q3 2026 Aarti Pharmalabs Ltd Earnings Call
Feb 10, 2026 / 10:30AM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Ladies and gentlemen, good day and welcome to RT Pharma Labs Q3 and 9 months F 26 earnings conference call hosted by Dollar Capital Markets Private Limited.

As a reminder, all participant lines will be in the listen-only mode, and there will be an opportunity for you to ask questions after the presentation concludes. Should you need assistance during this conference call, please signal an operator by pressing, then 0 on a touchstone phone. Please note that this conference is being recorded.

I now hand the conference over to Mr. Zen from Dollar Capital Markets Private Limited.

Thank you and over to you sir.

--------------------------------------------------------------------------------

Already have an account? Log in

Get the full story

Subscribe Now

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

7-Day Free Trial · Cancel Anytime

Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.